GSK suspends trial of drug formulated from red wine substance

05/5/2010 | Wall Street Journal, The

GlaxoSmithKline stopped a clinical trial of SRT501, a compound derived from the red wine substance resveratrol, in multiple myeloma patients after some of them developed cast nephropathy. GSK, which is developing the drug with Sirtris Pharmaceuticals, said its decision comes "out of an abundance of caution" as it reviews clinical data further.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA